Poolbeg Pharma has announced that the European Patent Office has granted its European Immunomodulator II patent application ...
“As the first biosimilar to Simponi (golimumab) to gain approval in the European market, we are committed to expanding access ...
Protara Therapeutics has announced encouraging interim results from its ongoing phase 2 STARBORN-1 trial evaluating TARA-002 ...
The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback